Excipient lung disease secondary to intravenous heroin use

Gretchen A Colbenson; Aahd Kubbara; Christian W Cox; Eunhee S Yi; Misbah Baqir

doi:10.1136/bcr-2021-247763

Article info

Case Reports: Reminder of important clinical lesson

Excipient lung disease secondary to intravenous heroin use

Authors

Gretchen A Colbenson Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Aahd Kubbara Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Christian W Cox Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Eunhee S Yi Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Misbah Baqir Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles

Citation

Colbenson GA, Kubbara A, Cox CW, et al

Excipient lung disease secondary to intravenous heroin use

BMJ Case Reports CP 2022;15:e247763.

Publication history

Accepted March 29, 2022
First published April 21, 2022.

Online issue publication

January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password